Azenta Inc
$ 27.16
2.14%
22 Jul - close price
- Market Cap 1,225,608,000 USD
- Current Price $ 27.16
- High / Low $ 27.22 / 26.17
- Stock P/E N/A
- Book Value 33.73
- EPS -2.44
- Next Earning Report 2026-08-04
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.01 %
- ROE -0.07 %
- 52 Week High 41.73
- 52 Week Low 15.93
About
Azenta Inc. is a premier provider of sample management solutions and life science tools, dedicated to enhancing laboratory efficiencies within the biotechnology and pharmaceutical industries. The company excels in innovative automation and comprehensive biorepository services, facilitating faster drug discovery while ensuring adherence to stringent regulatory standards. With a forward-looking strategy that leverages advanced storage technologies and strategic partnerships, Azenta is uniquely positioned to seize growth opportunities in the expanding global life sciences market. Its commitment to pioneering scientific research through sophisticated innovations underscores its potential appeal to institutional investors seeking exposure in the dynamic life sciences sector.
Analyst Target Price
$26.20
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-06 | 2026-02-04 | 2025-11-21 | 2025-08-05 | 2025-05-07 | 2025-02-05 | 2024-11-12 | 2024-08-06 | 2024-05-08 | 2024-02-07 | 2023-11-13 | 2023-08-08 |
| Reported EPS | -0.04 | 0.09 | 0.21 | 0.19 | 0.05 | 0.08 | 0.18 | 0.16 | 0.05 | 0.02 | 0.13 | 0.13 |
| Estimated EPS | 0.14 | 0.13 | 0.2 | 0.14 | 0.07 | 0.06 | 0.11 | 0.07 | 0.02 | -0.03 | 0.02 | -0.02 |
| Surprise | -0.18 | -0.04 | 0.01 | 0.05 | -0.02 | 0.02 | 0.07 | 0.09 | 0.03 | 0.05 | 0.11 | 0.15 |
| Surprise Percentage | -128.5714% | -30.7692% | 5% | 35.7143% | -28.5714% | 33.3333% | 63.6364% | 128.5714% | 150% | 166.6667% | 550% | 750% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-04 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | |
| Currency | USD |
Previous Dividend Records
| Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | None | None | None | None | None | None | None | None | None | None |
| Amount | $0.1 | $0.1 | $0.1 | $0.1 | $0.1 | $0.1 | $0.1 | $0.1 | $0.1 | $0.1 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: AZTA
2026-07-23 04:10:03
Azenta, Inc. will announce its fiscal third-quarter 2026 financial results after market close on August 4, 2026, for the period ending June 30, 2026. A conference call and live webcast will follow on August 5, 2026, at 8:30 a.m. Eastern Time to discuss these results. Azenta provides life sciences solutions globally, including cold-chain sample management and multiomics services.
2026-07-22 20:10:03
Azenta (Nasdaq: AZTA) will release its fiscal third-quarter 2026 earnings, covering the period ended June 30, 2026, on Tuesday, August 4, 2026, after the market close. A conference call and live webcast to discuss the results will be held on Wednesday, August 5, 2026, at 8:30 a.m. Eastern Time, with replay available from August 6, 2026. Interested parties can access the webcast via the company's investor relations website.
2026-07-22 20:10:03
Azenta, Inc. (Nasdaq: AZTA) will release its fiscal third quarter 2026 earnings on Tuesday, August 4, 2026, after market close. The company will then host a conference call and live webcast on Wednesday, August 5, 2026, at 8:30 a.m. Eastern Time to discuss these financial results. Investors and media can access the webcast and a replay via the Azenta website.
2026-07-20 16:11:56
Azenta's (AZTA) 2026 AGM highlighted a transformative year, disciplined strategy, and margin expansion, with $546 million in cash for strategic investments. The leadership stability was affirmed by the presence of most board members and the CEO. Financial performance showed meaningful growth in core businesses despite macroeconomic challenges.
2026-07-19 02:39:25
Azenta (AZTA) announced the acquisition of UK Biocentre for GBP 20.5 million, funded by cash on hand. This strategic move expands Azenta's European presence, particularly in the UK, and strengthens its life sciences biorepository operations. The acquisition is expected to be dilutive to Adjusted EBITDA margin in 2026 but accretive to revenue growth and margin expansion in 2027 and 2028, driven by operational and revenue synergies.
2026-07-18 15:39:25
This article provides a forecast and price target for Azenta, Inc. (BA3) stock, based on analyst opinions. It highlights the company's financial performance, including past earnings and revenue, and projected future earnings. Additionally, it offers information on the stock's highest and lowest prices ever, upcoming earnings dates, and how to buy its shares.
